Results 271 to 280 of about 484,364 (380)
Open-label placebo for non-specific pain in the emergency department (OLP EM): study protocol for a mixed-method randomised control feasibility study in Switzerland. [PDF]
Degen B+5 more
europepmc +1 more source
[Book Review of] \u3cem\u3eImplications of History and Ethics to Medicine: Veterinary and Human\u3c/em\u3e, edited by Lawrence B. McCullough and James Polk Morris, III [PDF]
Benjamin, Walter W.
core +1 more source
ABSTRACT Background Hypertrophic obstructive cardiomyopathy (HOCM) is a hereditary myocardial disease. Percutaneous endocardial septal radiofrequency ablation (PESA) is an innovative approach for treating HOCM. Consequently, we present the outcomes of the PESA for HOCM. Methods This study included 20 patients with HOCM who received PESA.
NingNing Zheng+6 more
wiley +1 more source
Effects of Open-Label Placebos on Visual Food Cue Reactivity in Children and Adolescents. [PDF]
Schienle A+4 more
europepmc +1 more source
Double blind evaluation of dyphylline, theophylline and placebo for exercise induced bronchospasm
C FURUKAWA+4 more
openalex +1 more source
Abstract Clascoterone is an androgen receptor inhibitor approved for the treatment of acne vulgaris in patients 12 years of age and older. Here, we report results of 5 phase 1 studies that assessed the pharmacokinetics (PK), safety, and skin irritation and sensitization potential of clascoterone cream 1% in healthy participants and patients with acne ...
Andrea Francesco Daniele Di Stefano+8 more
wiley +1 more source
Placebo Effects: Neurological Mechanisms Inducing Physiological, Organic, and Belief Responses-A Prospective Analysis. [PDF]
Niazi SK.
europepmc +1 more source
Lying to win-placebos and sport science.
S. Halson, David T. Martin
semanticscholar +1 more source
Abstract TAK‐071 is a novel muscarinic M1 positive allosteric modulator under investigation for the treatment of cognitive impairment and falls associated with Parkinson disease (PD). This study evaluated population pharmacokinetics of TAK‐071 following single (1‐160 mg) and multiple (3‐15 mg once daily) oral‐dose TAK‐071 in 112 healthy participants ...
Hongxia Jia+8 more
wiley +1 more source